Neuroleptic malignant syndrome and its controversies

B Margetić, BA Margetić - Pharmacoepidemiology and drug …, 2010 - Wiley Online Library
Purpose Neuroleptic malignant syndrome (NMS) is a rare and life threatening condition
usually defined as a complication of treatment with antipsychotics characterized by severe …

Neuroleptic malignant syndrome and its controversies

B Margetić, B Aukst-Margetić - … and drug safety, 2010 - pubmed.ncbi.nlm.nih.gov
Purpose Neuroleptic malignant syndrome (NMS) is a rare and life threatening condition
usually defined as a complication of treatment with antipsychotics characterized by severe …

[引用][C] Neuroleptic malignant syndrome and its controversies

B Margetić, BA Margetić - Pharmacoepidemiology and Drug Safety, 2010 - cir.nii.ac.jp
Neuroleptic malignant syndrome and its controversies | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

Neuroleptic malignant syndrome and its controversies.

B Margetić, B Aukst-Margetić - Pharmacoepidemiology and Drug …, 2010 - europepmc.org
Purpose Neuroleptic malignant syndrome (NMS) is a rare and life threatening condition
usually defined as a complication of treatment with antipsychotics characterized by severe …

Neuroleptic malignant syndrome and its controversies

B Margetić, BA Margetić - Pharmacoepidemiology and Drug Safety, 2010 - infona.pl
Purpose Neuroleptic malignant syndrome (NMS) is a rare and life threatening condition
usually defined as a complication of treatment with antipsychotics characterized by severe …

[引用][C] Neuroleptic malignant syndrome and its controversies

B MARGETIC - Pharmacoepidemiol Drug Saf., 2010 - cir.nii.ac.jp
Neuroleptic malignant syndrome and its controversies | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …